-
Mashup Score: 4Hodgkin Lymphoma - Mitigating Toxicity While Preserving Cure - Eight Year Data from MIOT International, Chennai, India - 5 month(s) ago
BackgroundOne of the most treatable cancers, Hodgkin’s lymphoma (HL), has a 5-year survival rate of approximately 85%.We still see relapse and refract…
Source: www.sciencedirect.comCategories: General Medicine News, Hematologists1Tweet
-
Mashup Score: 0
50K views, 173 likes, 3 loves, 2 comments, 14 shares, Facebook Watch Videos from Kombat Cancer: Multiple Myeloma is not known to everyone! Dr. Kishore Kumar, a senior consultant, Hematologist, and…
Source: fb.watchCategories: Hematologists1, Latest HeadlinesTweet
-
Mashup Score: 0Athlete PT Usha and music composer Ilayaraja among 4 nominated to Rajya Sabha | India News - Times of India - 2 year(s) ago
India News: Celebrated athlete P T Usha and iconic composer Ilaiyaraaja are among four people to be nominated to Rajya Sabha on Wednesday. Philanthropist Veerendr
Source: The Times of IndiaCategories: Hematologists1, Latest HeadlinesTweet
-
Mashup Score: 0‘Late diagnosis a concern in treating myeloma’ - 2 year(s) ago
Late diagnosis remains the major cause of concern in treating cases of myeloma, a type of blood cancer caused by malignancy of plasma cells originating in the bone marrow, said doctors who attended a conference on myolema at MIOT International hospital on Thursday.Vincent Rajkumar, Professor of Medicine and Haemato-Oncology, Mayo Clinic, Rochester, United States, a pioneer in the treatment of…
Source: www.thehindu.comCategories: Hematologists1, Latest HeadlinesTweet
-
Mashup Score: 0
In this video we are drawing a Caricature of Jeff Bezos.#nithinaadithya#caricatureofjeffbezos#infinitydrawings
Source: YouTubeCategories: Hematologists1, Latest HeadlinesTweet
-
Mashup Score: 0
In this video we are drawing a caricature of Elon Musk#nithinaadithya#caricatureofelonmusk#infinitydrawing
Source: YouTubeCategories: Hematologists1, Latest HeadlinesTweet
-
Mashup Score: 1
Abstract. Introduction:Bone marrow transplant, both Autograft and Allograft produces profound immune-suppression and breach of mucosal surfaces leading to many
Source: ashpublications.orgCategories: Hematologists1, Latest HeadlinesTweet
Hodgkin Lymphoma - Mitigating Toxicity While Preserving Cure - Y https://t.co/WJzhAmwcuc Our Eight-year data reveals a 93% 3-year EFS for early and 81% for advanced-stage, aligning with West.Consider Allo in 3rd line. Brentuximab, shows promise. #HodgkinLymphoma @HCC_HemeCancer